Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease
- PMID: 15357947
- DOI: 10.1016/j.immuni.2004.06.020
Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease
Abstract
A major function of NKG2D linking innate and adaptive immunity is to upregulate antigen-specific CTL-mediated cytotoxicity in tissues expressing stress-induced NKG2D ligands, such as MIC, by coactivating TCR signaling. Here, we show that, under conditions of dysregulated IL15 expression in vivo in patients with celiac disease and in vitro in healthy individuals, multiple steps of the NKG2D/DAP10 signaling pathway leading to ERK and JNK activation are coordinately primed to activate direct cytolytic function independent of TCR specificity in effector CD8 T cells. These findings may not only explain previous reports of transformation of CTL into NK-like "lymphokine-activated killers" (LAK cells) under high doses of IL2 (a substitute for IL15) but may also have significant implications for understanding and treating immunopathological diseases.
Comment in
-
Intraepithelial lymphocytes in celiac disease: license to kill revealed.Immunity. 2004 Sep;21(3):303-4. doi: 10.1016/j.immuni.2004.08.002. Immunity. 2004. PMID: 15357941
Similar articles
-
A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease.Immunity. 2004 Sep;21(3):367-77. doi: 10.1016/j.immuni.2004.06.018. Immunity. 2004. PMID: 15357948
-
Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors.Eur J Immunol. 2004 Apr;34(4):961-71. doi: 10.1002/eji.200324705. Eur J Immunol. 2004. PMID: 15048706
-
Cysteinyl leukotrienes mediate lymphokine killer activity induced by NKG2D and IL-15 in cytotoxic T cells during celiac disease.J Exp Med. 2015 Sep 21;212(10):1487-95. doi: 10.1084/jem.20150303. Epub 2015 Aug 24. J Exp Med. 2015. PMID: 26304964 Free PMC article.
-
NKG2D-mediated activation of cytotoxic lymphocytes: unique signaling pathways and distinct functional outcomes.Semin Immunol. 2006 Jun;18(3):167-75. doi: 10.1016/j.smim.2006.03.001. Epub 2006 May 24. Semin Immunol. 2006. PMID: 16723257 Review.
-
How NKG2D ligands trigger autoimmunity?Hum Immunol. 2006 Mar;67(3):204-7. doi: 10.1016/j.humimm.2006.02.013. Epub 2006 Mar 31. Hum Immunol. 2006. PMID: 16698443 Review.
Cited by
-
Bystander-activated memory CD8 T cells control early pathogen load in an innate-like, NKG2D-dependent manner.Cell Rep. 2013 Mar 28;3(3):701-8. doi: 10.1016/j.celrep.2013.02.020. Epub 2013 Mar 21. Cell Rep. 2013. PMID: 23523350 Free PMC article.
-
Therapeutic approaches for celiac disease.Best Pract Res Clin Gastroenterol. 2015 Jun;29(3):503-21. doi: 10.1016/j.bpg.2015.04.005. Epub 2015 May 9. Best Pract Res Clin Gastroenterol. 2015. PMID: 26060114 Free PMC article. Review.
-
Premature cell senescence and T cell receptor-independent activation of CD8+ T cells in juvenile idiopathic arthritis.Arthritis Rheum. 2013 Aug;65(8):2201-10. doi: 10.1002/art.38015. Arthritis Rheum. 2013. PMID: 23686519 Free PMC article.
-
NKG2D initiates caspase-mediated CD3zeta degradation and lymphocyte receptor impairments associated with human cancer and autoimmune disease.J Immunol. 2010 Nov 15;185(10):5732-42. doi: 10.4049/jimmunol.1002092. Epub 2010 Oct 6. J Immunol. 2010. PMID: 20926796 Free PMC article.
-
The current state of knowledge of the immune ecosystem in alopecia areata.Autoimmun Rev. 2022 May;21(5):103061. doi: 10.1016/j.autrev.2022.103061. Epub 2022 Feb 10. Autoimmun Rev. 2022. PMID: 35151885 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
